Navinci technology powers new spatial biomarker approach for predicting immunotherapy response

Navinci highlights a new preprint by Associate Professor Charlotte Stadler and collaborators, using in situ PLA to detect PD-1/PD-L1 interactions linked to immunotherapy response.